Abstract:Background: Autoantibodies against surface neuronal antigens have been associated with specific neurological presentations including autoimmune encephalitis (AE), with variable association with neoplasia and infections. Methods: We described the phenotype and environmental associations of patients with neurological syndromes associated with antibodies against neuronal surface antigens who were referred to a tertiary center in the South of Brazil. All patients were tested for neuronal autoantibodies using cell-based assays. Clinical, radiological, and laboratory findings were retrospectively reviewed. Results: We identified 16 patients, 15 had subacute, and one had a progressive disease course. Among patients with subacute onset, 11 (73 %) were N-Methyl-d-Aspartate receptor (NMDAr-IgG)+, 3 (20 %) were Leucine-rich Glioma-Inactivated-1 (LGI1-IgG)+, and 1 (6 %) was positive for Glycine receptor-IgG. The patient with a progressive disease course had antibodies against IgLON5. Most patients had disease onset in spring and summer suggesting environmental factors for the development of AE. Also, we observed a different pattern of brain lesions when NMDAr-IgG encephalitis followed herpes encephalitis and a previously unreported association with Rosai-Dorfman-Destombe disease. All patients with encephalopathy met criteria for possible AE and all proven NMDAr-IgG+ met criteria for NMDAr-IgG encephalitis. However, only one LGI1-IgG+ patient fulfilled clinical criteria for limbic encephalitis. All but one received high-dose intravenous methylprednisolone, 11 also had intravenous human immunoglobulin, and 4 plasma exchange. Furthermore, all patients received second-line immunotherapy. Importantly, most patients improved with immunotherapy, even when initiated later in the disease course. Conclusion: We identified seasonal variability associated with neuronal surface antibodies suggesting environmental triggers. Also, we described the coexistence of NMDAr-IgG encephalitis with histiocytosis. In our series, most patients received second-line immunotherapy. We observed neurologic improvement after treatment even in cases of delayed diagnosis. Increasing the recognition and availability of tests and treatments for these conditions is of paramount importance in low- and middle-income countries.

Identifying high-risk neurological phenotypes in adult-onset classic monogenic autoinflammatory diseases: when should neurologists consider testing?

Neurological manifestations of autoinflammatory diseases in Chinese adult patients

Neurological Involvement in a Portuguese Cohort of IgG4-Related Disease

Neurological syndromes and potential triggers associated with antibodies to neuronal surface antigens

The Clinical Characteristics of Neuronal Intranuclear Inclusion Disease and Its Relation with Inflammation

Mitochondrial diseases mimicking autoimmune diseases of the CNS and good response to steroids initially

Distinct phenotypes in a cohort of anti-CASPR2 associated neurological syndromes

The Clinical Spectrum of Autoimmune-Mediated Neurological Diseases in Paediatric Population

Inflammatory turmoil within: an exploration of autoinflammatory disease genetic underpinnings, clinical presentations, and therapeutic approaches

Clinical Features and Inflammatory Markers in Autoimmune Encephalitis Associated With Antibodies Against Neuronal Surface in Brazilian Patients

Overview and Diagnostic Approach in Autoimmune Neurology

Clinical characteristics and genetic analyses of 187 patients with undefined autoinflammatory diseases

Genetic diversity in hereditary axonal neuropathy: Analyzing 53 Brazilian children

Clinical and Genetic Aspects of Juvenile Amyotrophic Lateral Sclerosis: A Promising Era Emerges

Central Nervous System Involvement in Systemic Autoimmune Rheumatic Diseases-Diagnosis and Treatment

Peripheral innate immunophenotype in neurodegenerative disease: blood-based profiles and links to survival

Diagnostic Yield of Next-generation Sequencing in Very Early-onset Inflammatory Bowel Diseases: A Multicentre Study

Principles of clinical genetics for rheumatologists: clinical indications and interpretation of broad-based genetic testing

From Pathophysiology to Clinical Implications

The conundrum of neuropsychiatric systemic lupus erythematosus: Current and novel approaches to diagnosis